Neurocrine Bioscience buy Citigroup Inc.
Start price
07.04.26
/
50%
€112.90
Target price
07.04.27
€209.89
Performance (%)
-0.18%
Price
18:20
€112.70
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Neurocrine Bioscience is nearly unchanged. This prediction currently runs until 07.04.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -0.18% |
| iShares Core DAX® | 3,01 % |
| iShares Nasdaq 100 | 3,01 % |
| iShares Nikkei 225® | 4,14 % |
| iShares S&P 500 | 2,38 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Citigroup Inc. from $204.00 to $242.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€103.35
12.02.26
12.02.26
€171.73
12.02.27
12.02.27
9.05%
18:20
18:20
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.75
29.10.25
29.10.25
€174.28
29.10.26
29.10.26
-4.29%
18:20
18:20